Best in Biotech 25 Jan 2024
Eight mental health biotech companies trying to make a difference to people’s lives
Take a closer look at eight mental health companies developing therapies that could make a different to people with mental illnesses.
Search Results for: Mental health
News and Trends 23 Aug 2022
Freedom Biosciences exits stealth with $10.5M financing to develop mental health treatments
Freedom Biosciences, a U.S. clinical-stage biotech platform developing ketamine and psychedelic therapeutics, today emerged from stealth with $10.5 million in seed financing. MBX Capital led the round and was joined by PsyMed Ventures, Village Global and The Yale Startup, among others. The new financing will help the company advance its current lead ketamine program as […]
More News! 13 Jul 2022
Paradigm of treatment of mental health to be transformed by gut-brain development program
Building on a decade of research, a development program for next-generation probiotics and therapeutics to modulate gut microbiota and mental health has been launched. Seed Health, a microbiome science company along with Axial Therapeutics, a clinical stage biopharmaceutical company announced the joint program in the US today (July 13). It will build on the work […]
News and Trends 1 Jul 2020
UK Startup Bags €3M to Develop Psychedelic Medicines for Mental Health
A €3.3M (£3M) Series A round raised by the Oxford-based biomedicine company Beckley Psytech will allow the company to study the use of a psychedelic compound for the treatment of mental health disorders and neuropsychiatric disease. The investors include the UK VC firms Mediqventures and Jamjar Investments, which was set up by Richard Reed, co-founder […]
ADVERTISEMENT
News and Trends 11 Oct 2016
World Mental Health Day: How is Biotech Helping the Cause?
Biotech is one of the main forces driving the development of effective therapies to treat neurological and mental disorders. For World Mental Health Day yesterday, we want to share with you some of the latest technologies that address these conditions. Yesterday, October 10th, was World Mental Health Day: it is dedicated to raising awareness of neurological and mental disorders […]
In Depth 25 Mar 2024
Beyond Wegovy: Could Novo Nordisk’s new experimental weight loss pill be even better?
Discover how Novo Nordisk’s new experimental obesity pill, amycretin, could be even more efficient for weight loss than Wegovy.
Best in Biotech 27 Feb 2024
Japan’s ten hottest biotech companies in healthcare
While Japan historically lacked foreign investment the field is becoming more dynamic. Discover ten essential biotech companies in Japan.
Discover the synergy between biotech, medtech and digital health in Ghent, a European technology capital
News and Trends 5 Jun 2023
Bacterial resistance genes a ‘threat to human health’
Genes that make bacteria resistant to antibiotics are much more widespread in our environment than was previously realized. A new study, from Chalmers University of Technology and the University of Gothenburg in Sweden, shows that bacteria in almost all environments carry resistance genes, with a risk of them spreading and aggravating the problem of bacterial […]
News and Trends 27 Apr 2023
Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’
Arrowhead Pharmaceuticals Inc. has announced interim results from an ongoing phase 1/2 clinical study of ARO-RAGE, an investigational RNA interference (RNAi) therapeutic designed to reduce production of the receptor for advanced glycation end products (RAGE) as a potential treatment for inflammatory pulmonary diseases, such as asthma. These data represent the first clinical demonstration of the […]
News and Trends 9 Jan 2023
BC Platforms to collaborate on Singapore population health study
BC Platforms (BCP) has been selected to analyze and manage data collected from the Health for Life in Singapore (HELIOS) study, which forms part of the SG100K data set for Singapore’s National Precision Medicine program. The HELIOS study is a population cohort study established and led by the Lee Kong Chian School of Medicine (LKCMedicine) […]
News and Trends 9 Jan 2023
STALICLA signs agreement with Novartis on neurodevelopmental disorders
STALICLA SA, a clinical-stage biotech company advancing the first precision neurobiology platform for patients with neurodevelopmental disorders, has entered into an exclusive in-licensing agreement with Novartis to develop mavoglurant as a treatment for substance-use disorder and neurodevelopmental disorders (NDDs). Mavoglurant has previously been tested in more than 1,800 patients and demonstrated a good safety and […]